AstraZeneca and the University of Oxford’s experimental shot showed average efficacy of 70.4% in a pooled analysis of interim data from late-stage trials.
AstraZeneca and the University of Oxford’s experimental shot showed average efficacy of 70.4% in a pooled analysis of interim data from late-stage trials.